92 related articles for article (PubMed ID: 15676209)
1. Targeting IL-2 to the endoplasmic reticulum confines autocrine growth stimulation to NK-92 cells.
Konstantinidis KV; Alici E; Aints A; Christensson B; Ljunggren HG; Dilber MS
Exp Hematol; 2005 Feb; 33(2):159-64. PubMed ID: 15676209
[TBL] [Abstract][Full Text] [Related]
2. Characterization of stem cell factor gene-modified human natural killer cell line, NK-92 cells: implication in NK cell-based adoptive cellular immunotherapy.
Zhang J; Sun R; Wei H; Zhang J; Tian Z
Oncol Rep; 2004 May; 11(5):1097-106. PubMed ID: 15069553
[TBL] [Abstract][Full Text] [Related]
3. Interleukin-27 activates natural killer cells and suppresses NK-resistant head and neck squamous cell carcinoma through inducing antibody-dependent cellular cytotoxicity.
Matsui M; Kishida T; Nakano H; Yoshimoto K; Shin-Ya M; Shimada T; Nakai S; Imanishi J; Yoshimoto T; Hisa Y; Mazda O
Cancer Res; 2009 Mar; 69(6):2523-30. PubMed ID: 19244121
[TBL] [Abstract][Full Text] [Related]
4. IL-10 stimulatory effects on human NK cells explored by gene profile analysis.
Mocellin S; Panelli M; Wang E; Rossi CR; Pilati P; Nitti D; Lise M; Marincola FM
Genes Immun; 2004 Dec; 5(8):621-30. PubMed ID: 15573087
[TBL] [Abstract][Full Text] [Related]
5. Anti-myeloma activity of endogenous and adoptively transferred activated natural killer cells in experimental multiple myeloma model.
Alici E; Konstantinidis KV; Sutlu T; Aints A; Gahrton G; Ljunggren HG; Dilber MS
Exp Hematol; 2007 Dec; 35(12):1839-46. PubMed ID: 18036444
[TBL] [Abstract][Full Text] [Related]
6. Natural killer cells and gene therapy: potential of gene transfection for optimizing effector cell functions and for targeting gene products into tumor metastases.
Goldfarb RH; Whiteside TL; Basse PH; Lin WC; Vujanovic N; Herberman RB
Nat Immun; 1994; 13(2-3):131-40. PubMed ID: 8173234
[TBL] [Abstract][Full Text] [Related]
7. [Expression of recombinant mouse IL-1beta significantly down-regulates NK cell mediated cytolysis [corrected] against H22 hepatoma cells].
Xiao WL; Liang SJ; Mu DZ; Wang XJ; Wu HN
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2007 Dec; 23(12):1130-2. PubMed ID: 18062884
[TBL] [Abstract][Full Text] [Related]
8. Effect of cyclosporin A on interleukin-15-activated umbilical cord blood natural killer cell function.
Lin SJ; Kuo ML
Cytotherapy; 2008; 10(4):397-405. PubMed ID: 18574772
[TBL] [Abstract][Full Text] [Related]
9. Difference in cytotoxicity against hepatocellular carcinoma between liver and periphery natural killer cells in humans.
Ishiyama K; Ohdan H; Ohira M; Mitsuta H; Arihiro K; Asahara T
Hepatology; 2006 Feb; 43(2):362-72. PubMed ID: 16440347
[TBL] [Abstract][Full Text] [Related]
10. Characterization of natural killer and natural killer-like T cells derived from ex vivo expanded and activated cord blood mononuclear cells: implications for adoptive cellular immunotherapy.
Ayello J; van de Ven C; Cairo E; Hochberg J; Baxi L; Satwani P; Cairo MS
Exp Hematol; 2009 Oct; 37(10):1216-29. PubMed ID: 19638292
[TBL] [Abstract][Full Text] [Related]
11. Natural killer cells from protein kinase C theta-/- mice stimulated with interleukin-12 are deficient in production of interferon-gamma.
Page KM; Chaudhary D; Goldman SJ; Kasaian MT
J Leukoc Biol; 2008 May; 83(5):1267-76. PubMed ID: 18263766
[TBL] [Abstract][Full Text] [Related]
12. Genetically modified autoactivated cells expressing intracellular forms of GM-CSF as a model for regulated administration of cytokines.
Arteaga HJ; Mohamed AJ; Christensson B; Mahdy E; Gahrton G; Smith CI; Dilber MS
Scand J Immunol; 2005 Nov; 62(5):429-36. PubMed ID: 16305639
[TBL] [Abstract][Full Text] [Related]
13. Interleukin-15 improves cytotoxicity of natural killer cells via up-regulating NKG2D and cytotoxic effector molecule expression as well as STAT1 and ERK1/2 phosphorylation.
Zhang C; Zhang J; Niu J; Zhang J; Tian Z
Cytokine; 2008 Apr; 42(1):128-36. PubMed ID: 18280748
[TBL] [Abstract][Full Text] [Related]
14. Natural killer cell mediated cytotoxicity of tumor cells initiated by neem leaf preparation is associated with CD40-CD40L-mediated endogenous production of interleukin-12.
Bose A; Baral R
Hum Immunol; 2007 Oct; 68(10):823-31. PubMed ID: 17961770
[TBL] [Abstract][Full Text] [Related]
15. Interleukin-21 triggers both cellular and humoral immune responses leading to therapeutic antitumor effects against head and neck squamous cell carcinoma.
Nakano H; Kishida T; Asada H; Shin-Ya M; Shinomiya T; Imanishi J; Shimada T; Nakai S; Takeuchi M; Hisa Y; Mazda O
J Gene Med; 2006 Jan; 8(1):90-9. PubMed ID: 16097036
[TBL] [Abstract][Full Text] [Related]
16. Expression of interleukin-9 in nasal natural killer/T-cell lymphoma cell lines and patients.
Nagato T; Kobayashi H; Kishibe K; Takahara M; Ogino T; Ishii H; Oikawa K; Aoki N; Sato K; Kimura S; Shimizu N; Tateno M; Harabuchi Y
Clin Cancer Res; 2005 Dec; 11(23):8250-7. PubMed ID: 16322282
[TBL] [Abstract][Full Text] [Related]
17. Interleukin-12 improves cytotoxicity of natural killer cells via upregulated expression of NKG2D.
Zhang C; Zhang J; Niu J; Zhou Z; Zhang J; Tian Z
Hum Immunol; 2008 Aug; 69(8):490-500. PubMed ID: 18619507
[TBL] [Abstract][Full Text] [Related]
18. A programmed switch from IL-15- to IL-2-dependent activation in human NK cells.
Pillet AH; Bugault F; Thèze J; Chakrabarti LA; Rose T
J Immunol; 2009 May; 182(10):6267-77. PubMed ID: 19414780
[TBL] [Abstract][Full Text] [Related]
19. Augmentation of local antitumor immunity in liver by interleukin-2 gene transfer via portal vein.
Tanji H; Yahata H; Hayamizu K; Shinozaki K; Okimoto T; Sakaguchi T; Asahara T
Cancer Gene Ther; 2002 Aug; 9(8):655-64. PubMed ID: 12136426
[TBL] [Abstract][Full Text] [Related]
20. [Synergistic role between rhIL-2 and adriamycin long circulating temperature-sensitive liposome in targeting therapy on tumor].
Dong LF; Mei HS; Song SX; Lu ZJ
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2005 May; 21(3):296-300. PubMed ID: 15862144
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
